Partnering
Together we can shape the future of healthcare
:quality(90)/)
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
Combining Roche ’s strong position in companion diagnostics and Perseus’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers and create novel diagnostic tools.
We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and delivering them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.
Partnering with Pharma
>250 active global partnerships
50% of the medicines we brought to patients in the last decade were touched by a partner
140 people worldwide focused on bringing in and managing lasting partnerships
Partnering with Diagnostics
75 new agreements in 2025
24 acquisitions since 2014
+20 years of partnering with companies and research institutes globally to advance health
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)